MILD-COGNITIVE-IMPAIRMENT EVALUATION METHOD, CALCULATION METHOD, EVALUATION DEVICE, CALCULATION DEVICE, EVALUATION PROGRAM, CALCULATION PROGRAM, RECORDING MEDIUM, EVALUATION SYSTEM, AND TERMINAL DEVICE

Provided is the evaluating method and the like, which can provide reliable information that may be helpful in knowing a state of mild cognitive impairment. In the present embodiment, a state of mild cognitive impairment for a subject to be evaluated is evaluated using at least one value of concentra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NISHIMOTO, Rumi, UENO, Satoko, HARADA, Masashi, IKEUCHI, Takeshi, ARASHIDA, Naoko, KONDO, Hiroko, YANO, Yuki, SATO, Wataru
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Provided is the evaluating method and the like, which can provide reliable information that may be helpful in knowing a state of mild cognitive impairment. In the present embodiment, a state of mild cognitive impairment for a subject to be evaluated is evaluated using at least one value of concentration values of Put, α-ABA, Ala, Arg, Asn, Cit, Glu, Gln, Gly, His, Ile, Leu, Lys, Met, Orn, Phe, Pro, Ser, Thr, Trp, Tyr, Val, Taurine, 1-MeHis, 3-MeHis, aAAA, aAiBA, ADMA, Allyl Cys, bABA, bAiBA, Cystathionine, Cysteic acid, EtGly, GABA, hArg, Hypotaurine, Hypro, Kyn, Pyrazole-1-Ala, MCSO, MeCys, N6-AcLys, N8-AcSpd, Opthalmic acid, PEA, Pipecolic acid, Sar, SDMA, Spd, Spm, and Thioproline and test values of Alb, Folate, WBC, RBC, Hb, Ht, and PLT in blood of the subject.